Form 4: Solventum Corp Executive Paul S. Harrington Acquires Restricted Stock Units
SEC Form 4 Filing
Paul S. Harrington, Chief Supply Chain Officer of Solventum Corp, reports the acquisition of 11,879 Restricted Stock Units (RSUs) on May 13, 2024, according to a Form 4 filing with the SEC.
Summary
- Paul S. Harrington, Chief Supply Chain Officer at Solventum Corp, filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on May 13, 2024, where Mr. Harrington acquired 11,879 Restricted Stock Units (RSUs).
- These RSUs represent a contingent right to receive one share of Solventum Corp's Class A Common Stock upon settlement.
- The RSUs will vest in three equal tranches on May 13, 2025, May 13, 2026, and May 13, 2027, contingent upon continued service.
- Following the reported transaction, Mr. Harrington directly owns 11,879 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The RSU grant is a positive sign of aligning executive interests with company performance, but it's not an overwhelmingly positive event.
Positives
- The acquisition of RSUs aligns the executive's interests with those of the shareholders, incentivizing long-term performance.
Future Outlook
The vesting of the RSUs is contingent upon continued service, suggesting an expectation of Mr. Harrington's continued employment with Solventum Corp.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. This filing indicates Solventum's ongoing use of equity-based compensation to incentivize its executives.
Comparison to Industry Standards
- Equity compensation, such as RSUs, is a common practice among publicly traded companies to align executive interests with shareholder value.
- Companies like Johnson & Johnson and Medtronic, which operate in similar sectors, also utilize RSUs as part of their executive compensation packages.
- The vesting schedule of three years is fairly standard, aligning with typical performance evaluation cycles.
Stakeholder Impact
- The RSU grant aligns executive interests with shareholder value, potentially benefiting shareholders.
- The vesting schedule incentivizes the executive to remain with the company, providing stability.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of transaction: Acquisition of 11,879 Restricted Stock Units. |
| 05/13/2025 | First vesting date for one-third of the RSUs. |
| 05/13/2026 | Second vesting date for one-third of the RSUs. |
| 05/13/2027 | Final vesting date for one-third of the RSUs. |
| 05/15/2024 | Date of Form 4 filing. |
| 05/13/2034 | Expiration date of the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.